Primorus Investments PLC Exercise of Options in Zuuse Limited (7847L)

TIDMPRIM

RNS Number : 7847L

Primorus Investments PLC

15 September 2021

Primorus Investments PLC

Exercise of Options in Zuuse Limited

Primorus Investments PLC (the "Company"), the AIM listed investment company, is pleased to provide the following update regarding options held in one of its investee companies, Zuuse Limited ("Zuuse").

Zuuse is a Melbourne-based construction software vendor with operations in the UK, USA, Australia and New Zealand. Following participation in an investment round in late 2020, Primorus held 2,057,205 ordinary shares in Zuuse along with 1,000,000 options with an exercise price of A$0.50 per option (the "Options").

The Company has now exercised the Options for total consideration of A$500,000 (approximately GBP265,000). Following the exercise, the Company will hold 3,065,058 shares in Zuuse representing approximately 2.42 per cent. of Zuuse's issued share capital.

Zuuse performed well during the first half of 2021, with the revenue run-rate increasing to over A$20m at June 2021. This represented an annualised growth rate of 48% for the first half of 2021. In the year ended 31 December 2020, Zuuse reported turnover of A$17,995,000 and made a loss after tax of A$2,999,000.

Geoff Tarrant Executive Chairman of Zuuse said "We appreciate the continuing support of the Primorus team and remain optimistic on the outlook for our global business in 2022."

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

For further information, please contact:

Primorus Investments plc [phone]

Matthew Beardmore, Chief Executive Officer

Nominated Adviser and Broker

Cairn Financial Advisers LLP [phone]

Sandy Jamieson / James Caithie

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ACQDGGDCXUBDGBS

(END) Dow Jones Newswires

September 15, 2021 02:00 ET (06:00 GMT)